MyAverix Finance MyAverix Finance

F · Healthcare

BIO-WORKS TECHN. AB (1BD)

Biotechnology

BIO-WORKS TECHN. AB (1BD) is listed on F in the Healthcare sector. Industry: Biotechnology. As of 2026-03-22, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Data as of 2026-03-22

Download on the App Store Get it on Google Play

Download free on iPhone and Android

Key metrics for 1BD

P/E ratio
18.00

BIO-WORKS TECHN. AB (1BD) — FAQ

What is 1BD's P/E ratio?

The price-to-earnings (P/E) ratio for BIO-WORKS TECHN. AB (1BD) is 18.00 (data as of 2026-03-22).

Does BIO-WORKS TECHN. AB pay a dividend?

Dividend yield is not available in the current snapshot for BIO-WORKS TECHN. AB (1BD). Check the MyAverix Finance app for the latest dividend data.

What sector is BIO-WORKS TECHN. AB in?

BIO-WORKS TECHN. AB (1BD) is classified in the Healthcare sector (Biotechnology industry).

What exchange is 1BD listed on?

1BD is listed on F.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)

← All stocks

MyAverix Finance provides company information and financial data for educational and research purposes only. We are not a broker, advisor, or investment service. Data may be delayed or incomplete. Past performance does not guarantee future results. Always do your own research before making financial decisions.

Terms of Use

App Store Google Play